Annual Cash & Cash Equivalents
$27.65 M
+$8.25 M+42.53%
December 31, 2024
Summary
- As of March 10, 2025, NAUT annual cash & cash equivalents is $27.65 million, with the most recent change of +$8.25 million (+42.53%) on December 31, 2024.
- During the last 3 years, NAUT annual cash & cash equivalents has fallen by -$157.97 million (-85.11%).
- NAUT annual cash & cash equivalents is now -85.11% below its all-time high of $185.62 million, reached on December 31, 2021.
Performance
NAUT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$27.65 M
+$23.24 M+527.04%
December 31, 2024
Summary
- As of March 10, 2025, NAUT quarterly cash and cash equivalents is $27.65 million, with the most recent change of +$23.24 million (+527.04%) on December 31, 2024.
- Over the past year, NAUT quarterly cash and cash equivalents has increased by +$23.24 million (+527.04%).
- NAUT quarterly cash and cash equivalents is now -90.41% below its all-time high of $288.39 million, reached on June 30, 2021.
Performance
NAUT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NAUT Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +42.5% | +527.0% |
3 y3 years | -85.1% | -62.7% |
5 y5 years | -24.5% | -62.7% |
NAUT Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -85.1% | +42.5% | -86.9% | +527.0% |
5 y | 5-year | -85.1% | +42.5% | -90.4% | +527.0% |
alltime | all time | -85.1% | +42.5% | -90.4% | +527.0% |
Nautilus Biotechnology Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $27.65 M(+42.5%) | $27.65 M(+527.0%) |
Sep 2024 | - | $4.41 M(-82.3%) |
Jun 2024 | - | $24.89 M(-3.3%) |
Mar 2024 | - | $25.73 M(+32.6%) |
Dec 2023 | $19.40 M(-83.1%) | $19.40 M(-73.8%) |
Sep 2023 | - | $74.10 M(+2.7%) |
Jun 2023 | - | $72.14 M(-18.5%) |
Mar 2023 | - | $88.50 M(-22.7%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2022 | $114.52 M(-38.3%) | $114.52 M(-39.4%) |
Sep 2022 | - | $188.93 M(-10.2%) |
Jun 2022 | - | $210.35 M(+11.5%) |
Mar 2022 | - | $188.62 M(+1.6%) |
Dec 2021 | $185.62 M(+407.1%) | $185.62 M(-2.4%) |
Sep 2021 | - | $190.24 M(-34.0%) |
Jun 2021 | - | $288.39 M(+687.8%) |
Dec 2020 | $36.61 M | $36.61 M |
FAQ
- What is Nautilus Biotechnology annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Nautilus Biotechnology?
- What is Nautilus Biotechnology annual cash & cash equivalents year-on-year change?
- What is Nautilus Biotechnology quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Nautilus Biotechnology?
- What is Nautilus Biotechnology quarterly cash and cash equivalents year-on-year change?
What is Nautilus Biotechnology annual cash & cash equivalents?
The current annual cash & cash equivalents of NAUT is $27.65 M
What is the all time high annual cash & cash equivalents for Nautilus Biotechnology?
Nautilus Biotechnology all-time high annual cash & cash equivalents is $185.62 M
What is Nautilus Biotechnology annual cash & cash equivalents year-on-year change?
Over the past year, NAUT annual cash & cash equivalents has changed by +$8.25 M (+42.53%)
What is Nautilus Biotechnology quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NAUT is $27.65 M
What is the all time high quarterly cash and cash equivalents for Nautilus Biotechnology?
Nautilus Biotechnology all-time high quarterly cash and cash equivalents is $288.39 M
What is Nautilus Biotechnology quarterly cash and cash equivalents year-on-year change?
Over the past year, NAUT quarterly cash and cash equivalents has changed by +$23.24 M (+527.04%)